Getinge’s cardiac device sees 5th recall notice in 2023

About 16,000 of Getinge’s Cardiosave Hybrid and Rescue Intra-aortic Balloon Pumps have been recalled in 2023, according to the FDA. 

Advertisement

In late January, the agency said about 4,500 of the cardiac devices were recalled because of a risk of the balloon breaking, which can cause a device shutdown if blood enters the pump. Four serious injuries and one death were reported with the recall. None of the other recalls for the balloon pumps have reported injuries or deaths.

Unexpected shutdowns from coiled cord connection failures and circuit board communication issues led to two other recalls of about 6,800 devices in March. 

In August, the FDA reported another recall. The most recent case involved about 4,500 devices because of a risk of sudden power failure, and the agency said Aug. 17 the power issues were due to the device’s printed circuit board assembly in the charging path. 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Beyond the bottleneck: How health systems are improving access, flow and care continuity

Thursday, July 30
1:00 PM - 2:00 PM CDT

Presenters: Imamu Tomlinson, MD, MBA, VituityWilliam Morice II, MD, PhD, Mayo Clinic LaboratoriesJordan Dale, MD, Houston MethodistAsh Tengshe, City of HopeChris Klay, MHA, MA, PT, FACHE, Hospital Sisters Health System

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.